We are live on ! Find out more
Invesco

Invesco Portfolio holdings

AUM $1.02T
1-Year Est. Return 30.18%
 

Invesco Ltd., founded in 1978 and headquartered in Atlanta, Georgia, is a global investment management firm managing hundreds of billions in assets across a diverse range of products, including mutual funds, exchange-traded funds (ETFs), and institutional portfolios. Known for its blend of active and passive investment strategies, Invesco serves individual investors, financial advisors, and institutions, with a strong presence in North America, Europe, and Asia, bolstered by acquisitions like OppenheimerFunds in 2019. The firm offers specialized solutions in equities, fixed income, real estate, and alternatives, leveraging its global research capabilities to cater to varying market needs. Invesco’s commitment to innovation and client-focused investing has solidified its reputation as a versatile player in the asset management industry.

This Fund
S&P 500
This Quarter Est. Return
+0.71%
1 Year Est. Return
+30.18%
3 Year Est. Return
+96.06%
5 Year Est. Return
+126.45%
10 Year Est. Return
+482.58%
AUM
$255B
AUM Growth
-$3.63B
Cap. Flow
-$5.97B
Cap. Flow %
-2.34%
Top 10 Hldgs %
12.76%
Holding
4,482
New
462
Increased
1,845
Reduced
1,866
Closed
145

Top Buys

Rank Stock Value
1
EQIX icon
Equinix
EQIX
+$311M
2
EXR icon
Extra Space Storage
EXR
+$293M
3
KO icon
Coca-Cola
KO
+$246M
4
TCO
Taubman Centers Inc.
TCO
+$211M
5
NTAP icon
NetApp
NTAP
+$188M

Sector Composition

Rank Sector Weight
1 Technology 15.68%
2 Healthcare 14.19%
3 Financials 13.69%
4 Communication Services 8.77%
5 Real Estate 8.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ATEN icon
3901
A10 Networks
ATEN
$2.16B
$6K ﹤0.01%
+976
New +$5.46K
CCS icon
3902
Century Communities
CCS
$1.93B
$6K ﹤0.01%
+294
New +$5.91K
CHRS icon
3903
Coherus Oncology
CHRS
$221M
$6K ﹤0.01%
+197
New +$4.98K
CLAR icon
3904
Clarus
CLAR
$123M
$6K ﹤0.01%
656
-942
-59% -$8.88K
COLL icon
3905
Collegium Pharmaceutical
COLL
$1.14B
$6K ﹤0.01%
+310
New +$5.36K
CPRX
3906
DELISTED
Catalyst Pharmaceutical
CPRX
$6K ﹤0.01%
+1,382
New +$5.51K
CPS icon
3907
Cooper-Standard Automotive
CPS
$508M
$6K ﹤0.01%
101
-1,982
-95% -$123K
CRIS icon
3908
Curis
CRIS
$9.63M
$6K ﹤0.01%
+1
New +$6.01K
DJCO icon
3909
Daily Journal
DJCO
$824M
$6K ﹤0.01%
30
-244
-89% -$49.2K
DVAX
3910
DELISTED
Dynavax Technologies
DVAX
$6K ﹤0.01%
+250
New +$5.45K
ESCA icon
3911
Escalade
ESCA
$283M
$6K ﹤0.01%
317
-4,467
-93% -$81.9K
FC icon
3912
Franklin Covey
FC
$245M
$6K ﹤0.01%
306
-262
-46% -$5.11K
FOLD
3913
DELISTED
Amicus Therapeutics
FOLD
$6K ﹤0.01%
+391
New +$4.7K
FOXF icon
3914
Fox Factory Holding Corp
FOXF
$729M
$6K ﹤0.01%
+378
New +$6.09K
HBIO icon
3915
Harvard Bioscience
HBIO
$27.1M
$6K ﹤0.01%
+104
New +$5.92K
IRMD icon
3916
iRadimed
IRMD
$1.19B
$6K ﹤0.01%
+239
New +$4.37K
KE
3917
Kimball Electronics
KE
$595M
$6K ﹤0.01%
438
-2,053
-82% -$29.6K
LMAT icon
3918
LeMaitre Vascular
LMAT
$2.31B
$6K ﹤0.01%
+502
New +$4.94K
LOCO icon
3919
El Pollo Loco
LOCO
$500M
$6K ﹤0.01%
+304
New +$7.38K
MBUU icon
3920
Malibu Boats
MBUU
$543M
$6K ﹤0.01%
+290
New +$6.28K
MCHX icon
3921
Marchex
MCHX
$77.5M
$6K ﹤0.01%
+1,222
New +$5.73K
MPX
3922
DELISTED
Marine Products Corp
MPX
$6K ﹤0.01%
+968
New +$6.93K
PACB icon
3923
Pacific Biosciences
PACB
$444M
$6K ﹤0.01%
+1,052
New +$6.09K
PBPB
3924
DELISTED
Potbelly
PBPB
$6K ﹤0.01%
+498
New +$6.99K
RGLS
3925
DELISTED
Regulus Therapeutics
RGLS
$6K ﹤0.01%
4
-708
-99% -$1.14M

Similar funds

Invesco's Q2 2015 Portfolio in Review

As of Q2 2015, Invesco held 4,482 positions worth $255B, down 1.4% from $258B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Invesco's Q2 2015 filing shows 462 new, 1,845 increased, 1,866 reduced and 145 closed positions. Its largest new stake was Anthem, Inc.: 1,170,000 shares worth $61.6M. The largest sale was Fiat Chrysler Automobiles N.V., an estimated $3.11B.

By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 16% a quarter earlier, followed by Healthcare and Financials.

  • Invesco's largest Q2 2015 buy was Anthem, Inc.: 1,170,000 shares worth $61.6M.
  • Invesco added most to Equinix in Q2 2015, an estimated $311M increase.
  • Invesco's biggest Q2 2015 reduction was Fiat Chrysler Automobiles N.V., cutting an estimated $3.11B.
  • Invesco fully exited SALIX PHARMACEUTICALS LTD DEL in Q2 2015, selling an estimated $126M.
  • Invesco's ten largest holdings make up 13% of its $255B portfolio in Q2 2015.
  • Invesco opened 462 new positions and closed 145 in Q2 2015.
  • Invesco's portfolio value fell 1.4% quarter-over-quarter to $255B.

Based on Invesco's 13F filing for Q2 2015, filed 14 Aug 2015.